2024 Update in Clinical Cardiology: October 16-18, 2024
COURSE OVERVIEW
Update in Clinical Cardiology provides comprehensive updates for state-of-the-art care and guidance to incorporate them into daily practice to optimize patient outcomes. Coverage includes:
Coronary Artery Disease
Diabetes and Obesity
Valvular Heart Disease
Cardiac Biomarkers
Heart Failure (reduced and preserved ejection fraction)
Pulmonary Hypertension
Cardiomyopathies
Dyslipidemia
Hypertension
Atrial Fibrillation
Supraventricular Tachycardia
Ventricular Arrhythmias
Thoracic Aortic Disease
Pericarditis
Peripheral Arterial Disease
Renal Artery Stenosis
Pulmonary Embolism and Venous Thromboembolism
Cardio-oncology
Adult Congenital Heart Disease
Cardiac Critical Care
Ischemia with Non-Obstructive Coronary Arteries (INOCA)
Spontaneous Coronary Artery Dissection (SCAD)
Heart Disease in Pregnancy
Sports Cardiology
Endocarditis
The faculty is assembled from the best clinician-educators at Harvard Medical School and Massachusetts General Hospital and is designed to deliver the highest quality educational experience:
Teaching practical, effective clinical reasoning and approaches that enable you to practice state-of-the-art clinical cardiology
Allowing ample time for participants to interact with faculty and to pose and get answers to your specific questions, including Q&A sessions and case-based panel discussions
Providing the latest information in an engaging manner and clinically usable context so that you have knowledge you can “take home” and immediately apply to patient care
2024 PROGRAM HIGHLIGHTS
Management of obesity and diabetes for improved cardiovascular health outcomes
Use of GLP-1 agonists and SGLT2-inhibitors
Thoracic aortic disease Guideline Writing Committee chair, Dr. Eric M. Isselbacher, presents and answers your questions about the new guidelines for diagnosis and treatment
New clinical trials: data findings, updates, and implications for daily practice
Novel transcatheter and structural treatment options: important updates for the management of valvular disease
Optimized approaches to heart failure and cardiomyopathies, including hypertrophic cardiomyopathy and cardiac amyloidosis
Advances in electrical devices and mechanical support
Complex coronary artery disease management in the cath lab with novel diagnostic and revascularization techniques
Artificial intelligence (AI) and cardiovascular medicine
Reviews
There are no reviews yet.